Stock Analysts’ Updated EPS Estimates for July 20th (AARD, AORT, BRBY, DPLM, FDMT, FDUS, FNB, GNC, HD, IMAX)

Stock Analysts’ updated eps estimates for Monday, July 20th:

Aardvark Therapeutics (NASDAQ:AARD) had its neutral rating reiterated by analysts at HC Wainwright. The firm currently has a $6.00 price target on the stock.

Artivion (NYSE:AORT) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $44.00 target price on the stock.

Burberry Group (LON:BRBY) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a GBX 1,400 price target on the stock.

Diploma (LON:DPLM) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 9,000 target price on the stock.

4D Molecular Therapeutics (NASDAQ:FDMT) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $36.00 target price on the stock.

Fidus Investment (NASDAQ:FDUS) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. The firm currently has a $19.50 target price on the stock.

F.N.B. (NYSE:FNB) had its neutral rating reiterated by analysts at Bank of America Corporation. Bank of America Corporation currently has a $19.00 price target on the stock, down from their previous price target of $20.00.

Greencore Group (LON:GNC) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Home Depot (NYSE:HD) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $425.00 price target on the stock.

IMAX (NYSE:IMAX) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $47.00 price target on the stock.

MoonLake Immunotherapeutics (NASDAQ:MLTX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $45.00 price target on the stock.

Primoris Services (NYSE:PRIM) had its buy rating reaffirmed by analysts at Roth Capital. The firm currently has a $100.00 target price on the stock.

South32 (LON:S32) had its outperform rating reissued by analysts at Royal Bank Of Canada.

Sol-Gel Technologies (NASDAQ:SLGL) had its buy rating reissued by analysts at HC Wainwright. They currently have a $110.00 target price on the stock.

South Plains Financial (NASDAQ:SPFI) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $50.00 price target on the stock, up from their previous price target of $48.00.

Tempus AI (NASDAQ:TEM) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $75.00 target price on the stock.

Truist Financial (NYSE:TFC) had its underweight rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $53.00 price target on the stock, down from their previous price target of $53.50.